A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris

NCT01116895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: LEO 22811
DRUG: Placebo

Sponsor

LEO Pharma